Resources

Researchers find a new independent marker of silent myocardial ischemia in asymptomatic diabetic patients, osteoprotegerin.

Insulin-sensitizing treatment with metformin is not associated with a higher incidence of bone fractures, but current treatment with insulin increases the risk for fractures, according to the results of a nested case-control study.

Results of a study suggest that, free fatty acids empty from the stomach more slowly and suppress appetite more potently than triacylglycerides.

According to a new report in Diabetes Care, pioglitazone use is associated with an increased incidence of serious heart failure, but still provides clinical benefits, with no evidence that it increases subsequent mortality and morbidity

Their findings suggest that, with good diabetes control, this inflammation may be reduced, possibly resulting in a reduction of cardiovascular disease as well.

Millions of people with adult diabetes could one day be treated with a drug based on the healthy ingredient of red wine which could even help prevent other diseases linked with old age.

Researchers found that when adults with type 2 diabetes followed an individually tailored self-management program, they were better able to reduce both their weight and blood pressure, and maintain these benefits over time.

Obtaining islet cells from living donors may be a solution to the shortage of islets available for transplantation.

A meta-analysis of 4 randomized controlled trials of the weight-loss drug rimonabant concurs with Food and Drug Administration (FDA) findings of an increased risk for serious adverse psychiatric effects — depressed mood disorders and anxiety — although depressed mood was an exclusion criteria.

Patients with diabetes and low levels of HDL cholesterol, and high levels of homocysteine who have had a mild to moderate ischemic stroke were twice as likely as their counterparts without these conditions to have poorer cognitive function and greater disability after a stroke.